Lymphoplasmacytic Lymphoma Active Not Recruiting Phase 2 Trials for Ixazomib (DB09570)

IndicationStatusPhase
DBCOND0031072 (Lymphoplasmacytic Lymphoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02339922Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin LymphomaTreatment